About: Pregabalin is more effective than placebo for restless legs syndrome with mild adverse effects of daytime somnolence, headache and unsteadiness

Documentation

scienceplus.abes.fr version Bêta

scienceplus.abes.fr | explorer

À propos de : Pregabalin is more effective than placebo for restless legs syndrome with mild adverse effects of daytime somnolence, headache and unsteadiness Goto Sponge NotDistinct Permalink

Attributs	Valeurs
type	work Article
Is Part Of	http://hub.abes.fr/bmj/periodical/ebm/2011/volume_16/issue_1/w
Subject	Therapeutics
Title	Pregabalin is more effective than placebo for restless legs syndrome with mild adverse effects of daytime somnolence, headache and unsteadiness
has manifestation of work	http://hub.abes.fr/bmj/periodical/ebm/2011/volume_16/issue_1/B3555EDB41D738C5E053120B220A16A6/m/web http://hub.abes.fr/bmj/periodical/ebm/2011/volume_16/issue_1/B3555EDB41D738C5E053120B220A16A6/m/print
related by	http://hub.abes.fr/bmj/periodical/ebm/2011/volume_16/issue_1/B3555EDB41D738C5E053120B220A16A6/authorship/1
Abstract	Commentary on: Garcia-BorregueroDLarrosaOWilliamsAM. Treatment of restless legs syndrome with pregabalin: a double-blind, placebo-controlled study. Neurology2010;74:1897-904.
article type	other
publisher identifier	ebmed1127
is part of this journal	Evidence Based Medicine
PubMed ID	21081629

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata